63 reports

  • Musculoskeletal Drugs was the largest segment in the region market at 15.5% of the market worth about $6.4 billion.

Drugs For Respiratory Diseases P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A

  • Cholesterol
  • Dermatological Treatment
  • Managed Care
  • Respiratory Monitoring
  • Market Size

Particularly PDE-## and PDL-## inhibitors, the market is huge.

  • Cholesterol
  • Dermatological Treatment
  • Managed Care
  • World
  • Forecast
  • ORPHAN AND RARE DERMATOLOGY DRUGS MARKET, GLOBAL, APPROVED ORPHAN AND
  • 3.3 Highly Genericized Drugs

Stomach tests involve endoscopies (a popular technique to visualize internal body cavities) and gastrointestinal biopsies (taking a sample from inside the patient' s gastrointestinal tract for analysis).

  • Dermatological Treatment
  • World
  • AbbVie Inc.
  • Amryt Pharma plc
  • Celgene Corporation

Bile acid sequestrates lead to side effects related to the gastrointestinal tract.

  • Cardiovascular Disease
  • Cholesterol
  • Lipid Modifying Drug
  • Statins
  • AstraZeneca PLC
  • WELCHOL SWOT ANALYSIS, 2015

PLOS ONE; ##(##): ##-##.

  • Cholesterol
  • Managed Care
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • The Medicines Company

In April, Spectrum Health System named as one of the ## top health systems.

  • Hospital
  • Managed Care
  • United States
  • Company
  • Supply

Scope of Business: ##.

  • Cholesterol
  • Dermatological Treatment
  • Managed Care
  • China
  • Xian-Janssen Pharmaceutical Ltd.

Scope of Business: ##.

  • Cholesterol
  • Dermatological Treatment
  • China
  • Novartis AG
  • Xian-Janssen Pharmaceutical Ltd.

Systemic tetracycline may cause gastrointestinal upset, nausea, diarrhea, and vaginal yeast infection.

  • Dermatological Treatment
  • Managed Care
  • Allergan plc
  • Galderma S.A.
  • Pfizer Inc.

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Respiratory Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • CareFusion Corporation
  • WELCHOL (COLESEVELAM HCL) SWOT ANALYSIS, 2014

GASTROINTESTINAL SIDE EFFECTS WERE THE MOST COMMON AND INCLUDED ERUCTATION, DIARRHEA, AND NAUSEA.

  • Cholesterol
  • Managed Care
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • WELCHOL (COLESEVELAM HCL) SWOT ANALYSIS, 2014

GASTROINTESTINAL SIDE EFFECTS WERE THE MOST COMMON AND INCLUDED ERUCTATION, DIARRHEA, AND NAUSEA.

  • Cholesterol
  • Managed Care
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • WELCHOL (COLESEVELAM HCL) SWOT ANALYSIS, 2014

GASTROINTESTINAL SIDE EFFECTS WERE THE MOST COMMON AND INCLUDED ERUCTATION, DIARRHEA, AND NAUSEA.

  • Cholesterol
  • Managed Care
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • WELCHOL (COLESEVELAM HCL) SWOT ANALYSIS, 2014

GASTROINTESTINAL SIDE EFFECTS WERE THE MOST COMMON AND INCLUDED ERUCTATION, DIARRHEA, AND NAUSEA.

  • Cholesterol
  • Managed Care
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

B-## Table of Contents iv U. S.

  • Dermatological Treatment
  • Managed Care
  • United States
  • Covidien plc
  • Smith & Nephew Plc
  • Aug 11, 2017: Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • Nov 07, 2017: Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Third Quarter 2017 Financial Results

Inhibition of Niemann-Pick C##-Like ## (NPC##L##) by ezetimibe results in reduced absorption of cholesterol from the gastrointestinal tract, thereby reducing delivery of cholesterol to the liver, which in turn upregulates LDL receptors.

  • Cholesterol
  • Therapy
  • United States
  • Deals & Alliance
  • Esperion Therapeutics, Inc.
  • PIPELINE BY EA PHARMA CO LTD, H2 2018
  • INTRODUCTION

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Dermatological Treatment
  • Pharmaceutical
  • World
  • Product Initiative
  • Gilead Sciences, Inc.
  • SMALL MOLECULE TO ANTAGONIZE GABAA RECEPTOR FOR METABOLIC, GASTROINTESTINAL AND CARDIOVASCULAR DISORDERS - DRUG PROFILE
  • DYSLIPIDEMIA - PIPELINE BY SJT MOLECULAR RESEARCH SL, H1 2018

Dyslipidemia - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Dyslipidemia - Pipeline Review, H1 2018, provides an overview of the Dyslipidemia (Metabolic Disorders) pipeline landscape. Dyslipidemia is defined as elevation...

  • Cholesterol
  • Chronic Disease
  • Managed Care
  • Pharmaceutical
  • Amarin Corporation plc

There were ## serious adverse events in the study, both unrelated to treatment, one in a placebo and one in a drug-treated patient.

  • Cholesterol
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Synta Pharmaceuticals Corp.

S##. and Rehabilitation; ##(##): ##-##.

  • Cholesterol
  • Managed Care
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

There were ## serious adverse events in the study, both unrelated to treatment, one in a placebo and one in a drug-treated patient.

  • Cholesterol
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Synta Pharmaceuticals Corp.
  • FRESENIUS MEDICAL CARE AG & CO KGAA, DEALS BY THERAPY AREA, 2012 TO YTD 2018

DIALYSIS TREATMENTS INCREASED BY ##%.

  • Managed Care
  • Australia
  • United States
  • Company Financials
  • Fresenius Group
  • SMALL MOLECULE TO ANTAGONIZE GABAA RECEPTOR FOR METABOLIC, GASTROINTESTINAL AND CARDIOVASCULAR DISORDERS - DRUG PROFILE
  • DYSLIPIDEMIA - PIPELINE BY SJT MOLECULAR RESEARCH SL, H2 2018

Dyslipidemia - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Dyslipidemia - Pipeline Review, H2 2018, provides an overview of the Dyslipidemia (Metabolic Disorders) pipeline landscape. Dyslipidemia is defined as elevation...

  • Cholesterol
  • Chronic Disease
  • Managed Care
  • United States
  • Amarin Corporation plc

The majority of AEs were gastrointestinal.

  • Cholesterol
  • Therapy
  • United States
  • Company
  • Gemphire Therapeutics Inc.
  • Mayo Foundation for Medical Education and Research, Deals By Therapy Area, 2011 to YTD 2017

Deal Rationale Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products.

  • Cholesterol
  • Clinic
  • Dermatological Treatment
  • Managed Care
  • GlobalData's company

One unit is one oximeter sensor.

  • Managed Care
  • Respiratory Monitoring
  • United States
  • Company
  • GlobalData's company

The company' s major products include analgesics, gastrointestinal, personal care and derma therapeutics, colobetasol spray, clindamycin foam, mupirocin ointment, halobetasol ointment and cream and permethrin cream.

  • Dermatological Treatment
  • Israel
  • United States
  • Company
  • Perrigo Company

The company' s major products include analgesics, gastrointestinal, personal care and derma therapeutics, colobetasol spray, clindamycin foam, mupirocin ointment, halobetasol ointment and cream and permethrin cream.

  • Dermatological Treatment
  • Israel
  • United States
  • Company
  • Perrigo Company

ONE UNIT REFERS TO ONE PEAK FLOW METER.

  • Managed Care
  • Respiratory Monitoring
  • Southern Europe
  • Western Europe
  • Medtronic, Inc.

Major gastrointestinal diseases include irritable bowel syndrome, Crohn' s disease, cirrhosis, liver diseases and hepatitis C infection (HCV), among others.

  • Health Services
  • Hospital
  • Managed Care
  • United States
  • Company